Equities

Linical Co Ltd

2183:TYO

Linical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)400.00
  • Today's Change2.00 / 0.50%
  • Shares traded20.20k
  • 1 Year change-41.86%
  • Beta0.7057
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income6601,3791,032
Depreciation/depletion171181169
Non-Cash items115(205)233
Cash taxes paid, supplemental625280399
Cash interest paid, supplemental181314
Changes in working capital(228)166(74)
Total cash from operations1,0651,8401,632
INVESTING
Capital expenditures(33)(13)(46)
Other investing and cash flow items, total4.46(0.95)67
Total cash from investing(29)(14)21
FINANCING
Financing cash flow items----0.00
Total cash dividends paid(316)(316)(316)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(645)(641)(636)
Total cash from financing(961)(957)(952)
NET CHANGE IN CASH
Foreign exchange effects347188200
Net change in cash4231,056901
Net cash-begin balance/reserved for future use7,0425,9865,084
Net cash-end balance/reserved for future use7,4657,0425,986
SUPPLEMENTAL INCOME
Depreciation, supplemental171181169
Cash interest paid, supplemental181314
Cash taxes paid, supplemental625280399
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.